Here’s why Intra-Cellular Therapies, Inc. (ITCI) Stock Dropped in Aftermarket
Intra-Cellular Therapies, Inc. (ITCI) is a leading novel biotherapeutic company developing therapies for treating neuropsychiatric and neurologic patients. The company also treats schizophrenia patients using